A detailed history of Dynamic Technology Lab Private LTD transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 59,278 shares of FOLD stock, worth $580,331. This represents 0.07% of its overall portfolio holdings.

Number of Shares
59,278
Previous 70,331 15.72%
Holding current value
$580,331
Previous $698,000 9.31%
% of portfolio
0.07%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$9.55 - $12.09 $105,556 - $133,630
-11,053 Reduced 15.72%
59,278 $633,000
Q2 2024

Aug 14, 2024

BUY
$9.04 - $11.75 $238,050 - $309,412
26,333 Added 59.85%
70,331 $698,000
Q1 2024

May 14, 2024

BUY
$11.43 - $14.24 $502,897 - $626,531
43,998 New
43,998 $518,000
Q1 2023

May 12, 2023

BUY
$10.91 - $13.54 $82,872 - $102,849
7,596 Added 30.74%
32,307 $358,000
Q4 2022

Feb 13, 2023

SELL
$9.89 - $12.7 $98,000 - $125,844
-9,909 Reduced 28.62%
24,711 $302,000
Q3 2022

Nov 14, 2022

BUY
$9.82 - $12.75 $339,968 - $441,405
34,620 New
34,620 $361,000
Q4 2021

Feb 14, 2022

SELL
$9.82 - $12.44 $709,809 - $899,188
-72,282 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$8.74 - $11.84 $631,744 - $855,818
72,282 New
72,282 $690,000
Q1 2020

May 13, 2020

SELL
$6.63 - $11.16 $176,888 - $297,748
-26,680 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$7.48 - $10.75 $70,169 - $100,845
-9,381 Reduced 26.01%
26,680 $260,000
Q3 2019

Nov 14, 2019

BUY
$8.02 - $13.25 $89,126 - $147,247
11,113 Added 44.54%
36,061 $289,000
Q2 2019

Aug 14, 2019

BUY
$10.96 - $14.4 $273,430 - $359,251
24,948 New
24,948 $311,000
Q4 2018

Feb 13, 2019

SELL
$8.38 - $13.44 $119,465 - $191,600
-14,256 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$11.6 - $16.54 $165,369 - $235,794
14,256 New
14,256 $172,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.75B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.